Marker Therapeutics, Inc. (MRKR)
NASDAQ: MRKR · Real-Time Price · USD
0.8532
+0.0166 (1.98%)
At close: Nov 18, 2026, 4:00 PM EST
0.8532
0.00 (0.00%)
After-hours: Nov 18, 2026, 4:00 PM EST
Marker Therapeutics Market Cap
Marker Therapeutics has a market cap or net worth of $14.23 million as of November 18, 2026. It is the 39,116th most valuable company in the world and the 5,324th biggest in the United States. Its market cap has decreased by 10.53% in one year.
Market Cap
14.23M
Enterprise Value
5.19M
1-Year Change
-10.53%
Global Rank
Country Rank
#5,324 United States
Category
ChartMarket Cap Chart
Since November 8, 2016, Marker Therapeutics's market cap has decreased from $45.80M to $14.23M, a decrease of -68.94%. That is a compound annual growth rate of -11.00%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 18, 2026 | 14.23M | -42.64% |
| Dec 31, 2025 | 24.80M | -10.79% |
| Dec 31, 2024 | 27.80M | -43.15% |
| Dec 29, 2023 | 48.90M | 120.27% |
| Dec 30, 2022 | 22.20M | -71.86% |
| Dec 31, 2021 | 78.90M | 13.36% |
| Dec 31, 2020 | 69.60M | -47.15% |
| Dec 31, 2019 | 131.70M | -47.70% |
| Dec 31, 2018 | 251.80M | 509.69% |
| Dec 29, 2017 | 41.30M | 27.08% |
| Dec 30, 2016 | 32.50M | -29.04% |
| Nov 8, 2016 | 45.80M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Pasithea Therapeutics | 14.51M |
| Estrella Immunopharma | 14.42M |
| Seres Therapeutics | 14.37M |
| Citius Pharmaceuticals | 14.24M |
| Quantum BioPharma | 13.93M |
| Actuate Therapeutics | 13.84M |
| Passage Bio | 13.58M |
| Tvardi Therapeutics | 13.47M |